Abstract
A large body of clinical and experimental studies implicates free radical mechanisms in the pathogenesis of alcoholic liver disease (ALD). Ethanol-induced oxidative stress is the result of the combined impairment of antioxidant defenses and the stimulation of reactive oxygen species (ROS) production by the mitochondrial electron transport chain, the alcohol-inducible cytochrome P4502E1 (CYP2E1), and activated phagocytes. Furthermore, hydroxyethyl free radicals (HER) are also generated during ethanol metabolism by CYP2E1. The mechanisms by which oxidative stress contributes to alcohol toxicity involve mitochondrial permeability transition, endoplasmic reticulum stress, and impairment of hepatocyte pro-survival signals. Moreover, oxidative mechanisms contribute to the stimulation of hepatic inflammation by directly stimulating phagocyte activation and by promoting adaptive immune responses. Finally oxidative stress favors the evolution of ALD to liver fibrosis by promoting the release of pro-fibrotic cytokines and the activation of hepatic stellate cells. Altogether these observations give a rationale to the possible clinical application of antioxidants in the therapy of ALD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mandayam S, Jamal MM, Morgan TR (2004) Epidemiology of alcoholic liver disease. Semin Liver Dis 24:217–232
Tzukamoto H (2007) Conceptual importance of identifying alcoholic liver disease as a lifestyle disease. J Gastroenterol 42:603–609
Bell BP, Manos MM, Zaman A, Terrault N, Thomas A, Navarro VJ, Dhotre KB, Murphy RC, Van Ness GR, Stabach N, Robert ME, Bower WA, Bialik SR, Sofair AN (2008) The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance. Am J Gastroenterol 103:1–10
Zakhari S, Kai LT (2007) Determinants of alcohol use and abuse: impact of quantity and frequency patterns on the liver. Hepatology 46:2032–2039
O’Shea R, Dasarathy S, McCullough AJ, Practice Guideline Committee of the American Association for the Study of Liver Diseases and the Practice Committee of the American College of Gastroenterology (2010) Alcoholic liver disease. Hepatology 51:307–328
Sheron N, Oslen N, Gilmore I (2008) An evidence based alcohol reduction policy. Gut 57:1341–1344
Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F (2013) The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol 58:593–608
Corrao G, Bagnardi V, Zambon A, La Vecchia C (2004) A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med 38:613–619
Bellentani S, Saccoccio G, Costa G, Tiribelli C, Manenti F, Sodde M, Saveria Crocè L, Sasso F, Pozzato G, Cristianini G, Brandi G (1977) Drinking habitus as co factor of the risk of alcohol-induced liver damage. Gut 41:845–850
Kamper-Jorgensen M, Gronback M, Tolstrup J, Becker U (2004) Alcohol and cirrhosis: dose-response or threshold effect? J Hepatol 41:25–30
Morgan TR, Mandayam S, Jamal MM (2004) Alcohol and hepatocellular carcinoma. Gastroenterology 127:587–596
Seitz HK, Stickel F (2007) Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 7:599–612
Stickel F, Hampe J (2012) Genetic determinants of alcoholic liver disease. Gut 61:150–159
Crabb DW, Liangpunsakul S (2007) Acetaldehyde generating enzymes: roles of alcohol dehydrogenase, CYP2E1 and catalase, and speculation on the role of the others enzymes and processes. In: Chadwick DJ, Goode J (eds) Acetaldehyde-related pathology; bridging the transdisciplinary divide. Wiley, Chichister, pp 4–16
Cederbaum AL (2012) Alcohol metabolism. Clin Liver Dis 16:667–685
Lu Y, Cederbaum AL (2008) CYP2E1 and oxidative liver injury by alcohol. Free Radic Biol Med 44:723–738
Liangpunsakul S, Kolwankar D, Pinto A, Gorski CJ, Hall SD, Chalasani N (2005) Activity of CYP2E1 and CYP3A enzymes in adults with moderate alcohol consumption: a comparison with nonalcoholics. Hepatology 41:1144–1150
Dupont I, Lucas D, Clot P, Ménez C, Albano E (1998) Cytochrome P4502E1 inducibility and hydroxyethyl radical formation among alcoholics. J Hepatol 28:564–571
Neve EP, Ingelman-Sundberg M (2008) Intracellular transport and localization of microsomal cytochrome P450. Anal Bioanal Chem 392:1075–1084
Deitrich RA, Petersen D, Vasiluou V (2007) Removal of acetaldehyde from the body. In: Chadwick DJ, Goode J (eds) Acetaldehyde-related pathology; bridging the transdisciplinary divide. Wiley, Chichister, pp 23–40
Singh S, Brocker C, Koppaka V, Chen Y, Jackson BC, Matsumoto A, Thompson DC, Vasiliou V (2013) Aldehyde dehydrogenases in cellular responses to oxidative/electrophilic stress. Free Radic Biol Med 56:89–101
Di Luzio NR (1963) Prevention of acute ethanol-induced fatty liver by antioxidants. Physiologist 6:169–173
Nordmann R, Ribière C, Rouach H (1992) Implication of free radical mechanisms in ethanol induced cellular injury. Free Radic Biol Med 12:219–240
Albano E (2008) New concept in the pathogenesis of alcoholic liver disease. Expert Rev Gastroenterol Hepatol 2:749–759
Clot P, Tabone M, Aricò S, Albano E (1994) Monitoring oxidative damage in patients with liver cirrhosis and different daily alcohol intake. Gut 35:1637–1643
Aleynik SI, Leo MA, Aleynik MK, Lieber CS (1998) Increased circulating products of lipid peroxidation in patients with alcoholic liver disease. Alcohol Clin Exp Res 22:192–196
Meager EA, Barry OP, Burke A, Lucey MR, Lawson JA, Rokach J, FitzGerald GA (1999) Alcohol-induced generation of lipid peroxidation products in humans. J Clin Invest 104:805–813
Yang L, Latchoumycandane C, McMullen MR, Pratt BT, Zhang R, Papouchado BG, Nagy LE, Feldstein AE, McIntyre TM (2010) Chronic alcohol exposure increases circulating bioactive oxidized phospholipids. J Biol Chem 285:22211–22220
Niemelä O, Parkkila S, Ylä-Herttuala S, Halsted C, Witztum JL, Lanca A, Israel Y (1994) Covalent protein adducts in the liver as a result of ethanol metabolism and lipid peroxidation. Lab Invest 70:537–546
Nanji AA, Zhao S, Sadrzadeh SMH, Dannenberg AJ, Tahan SR, Waxman DJ (1994) Markedly enhanced cytochrome P4502E1 induction and lipid peroxidation is associated with severe liver injury in fish oil-treated ethanol-fed rats. Alcohol Clin Exp Res 18:1280–1285
Polavarapu R, Spitz DR, Sim JE, Follansbee MH, Oberley LW, Rahemtulla A, Nanji AA (1998) Increased lipid peroxidation and impaired antioxidant enzyme function is associated with pathological liver injury in experimental alcoholic liver disease in rats fed diets high in corn oil and fish oil. Hepatology 27:1317–1323
Nanji AA, Yang EK, Fogt F, Sadrzadeh SMH, Dannenberg AJ (1996) Medium chain triglycerides and vitamin E reduce the severity of established experimental alcoholic liver disease. J Pharmacol Exper Ther 277:1694–1700
Nanji AA, Sadrzadeh SMH, Yang EK, Fogt F, Maydani M, Dannenberg AJ (1995) Dietary saturated fatty acids: a novel treatment for alcoholic liver disease. Gastroenterology 109:547–554
Arteel GE (2003) Oxidants and antioxidants in alcohol-induced liver disease. Gastroenterology 124:778–790
Cohen JI, Roychowdhury S, DiBello PM, Jacobsen DW, Nagy LE (2009) Exogenous thioredoxin prevents ethanol-induced oxidative damage and apoptosis in mouse liver. Hepatology 49(5):1709–1717
Ronis MJJ, Butura A, Sampey BP, Prior RL, Korourian S, Albano E, Ingelman-Sundberg M, Petersen DR, Badger TM (2005) Effects of N-acetyl cysteine on ethanol-induced hepatotoxicity in rats fed via total enteral nutrition. Free Radic Biol Med 39:619–630
Wheeler MD, Kono H, Yin M, Rusyn I, Froh M, Connor HD, Mason RP, Samulski RJ, Thurman RG (2001) Delivery of Cu/Zn-superoxide dismutase gene with adenovirus reduces early alcohol-induced liver injury in rats. Gastroenterology 120:1241–1250
Wheeler MD, Nakagami M, Bradford BU, Uesugi T, Mason RP, Connor HD, Dikalova A, Kadiiska M, Thurman RG (2001) Overexpression of manganese superoxide dismutase prevents alcohol-induced liver injury in the rat. J Biol Chem 276:36664–36672
Kessova IG, Ho YS, Thung S, Cederbaum AI (2003) Alcohol-induced liver injury in mice lacking Cu, Zn-superoxide dismutase. Hepatology 38:1136–1145
Lamlé J, Marhenke S, Borlak J, von Wasielewski R, Eriksson PCJ, Geffers R, Manns MP, Yamamoto M, Vogel A (2008) Nuclear factor-eythroid 2-related factor prevents alcohol-induced fulminant liver injury. Gastroenterology 134:1159–1168
Bailey SM, Cunningham CC (2002) Contribution of mitochondria to oxidative stress associated with alcohol liver disease. Free Radic Biol Med 32:11–16
Hoek JB, Cahill A, Pastorino JG (2002) Alcohol and mitochondria: a dysfunctional relationship. Gastroenterology 122:2049–2063
Venkatraman A, Landar A, Davis AJ, Chamlee L, Sanderson T, Kim H, Page G, Pompilius M, Ballinger S, Darley-Usmar V, Bailey SM (2004) Modification of the mitochondrial proteome in response to the stress of ethanol-dependent hepatotoxicity. J Biol Chem 279:22092–22101
Garcia-Ruiz C, Colell A, Paris R, Fernandez-Checa JC (2000) Direct interaction of GD3 ganglioside with mitochondria generates reactive oxygen species followed by mitochondrial permeability transition, cytochrome c release and caspase activation. FASEB J 14:847–850
Konckaert L, Fromenty B, Robin MA (2011) Mechanisms of mitochondrial targeting of cytochrome P4502E1: physiopathological role in liver injury and obesity. FEBS J 278:4252–4280
Bansal S, Liu CP, Sepuri NB, Anandatheerthavarada HK, Selvaraj V, Hoek J, Milne GL, Guengerich FP, Avadhani NG (2010) Mitochondria-targeted cytochrome P450 2E1 induces oxidative damage and augments alcohol-mediated oxidative stress. J Biol Chem 285:24609–24619
Frank A, Seitz HK, Bartsch H, Frank N, Nair J (2004) Immunohistochemical detection of 1, N6-ethenodeoxyadenosine in nuclei of human liver affected by diseases predisposing to hepatocarcinogenesis. Carcinogenesis 25:1027–1031
Hu W, Feng Z, Eveleigh J, Iyer G, Pan J, Amin S, Chung FL, Tang MS (2002) The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hot spot in hepatocellular carcinoma. Carcinogenesis 23:1781–1789
Albano E, Clot P, Morimoto M, Tomasi A, Ingelman-Sundberg M, French SW (1996) Role of cytochrome P4502E1-dependent formation of hydroxyethyl free radicals in the development of liver damage in rats intragastrically fed with ethanol. Hepatology 23:155–163
Kono H, Bradford BU, Yin M, Sulik KK, Koop DR, Peters JM, Gonzalez FJ, McDonald T, Dikalova A, Kadiiska MB, Mason RP, Thurman RG (1999) CYP2E1 is not involved in early alcohol-induced liver injury. Am J Physiol 277:G1259–G1267
Bradford BU, Kona H, Isayama F, Kosyk O, Wheeler MD, Akiyama TE, Bleye L, Krausz KW, Gonzalez FJ, Koop DR, Rusyn I (2005) Cytochrome P450 CYP2E1, but not nicotinamide adenine dinucleotide phosphate oxidase is required for ethanol-induced oxidative DNA damage in rodent liver. Hepatology 41:336–344
Morgan K, French SW, Morgan TR (2002) Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damage. Hepatology 36:122–134
Lu Y, Wu D, Wang X, Ward SC, Cederbaum AI (2010) Chronic alcohol-induced liver injury and oxidant stress are decreased in cytochrome P4502E1 knockout mice and restored in humanized cytochrome P4502E1 knock-in mice. Free Radic Biol Med 49:1406–1416
Pail YH, Kim J, Aoyama T, De Minicis S, Battalier R, Brenner DA (2014) Role of NADPH oxidase in liver fibrosis. Antioxid Redox Signal 20:2854–2872
Hines IN, Wheeler MD (2004) Recent advances in alcoholic liver disease III. Role of the innate immune response in alcoholic hepatitis. Am J Physiol Gastrointest Liver Physiol 287:G310–G314
Kono H, Rusyn I, Yin M, Gabele E, Yamashina S, Dikalova A, Kadiiska MB, Connor HD, Mason RP, Segal BH, Bradford BU, Holland SM, Thurman RG (2000) NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. J Clin Invest 106:867–872
Kono H, Uesugi T, Froh M, Rusyn I, Bradford BU, Thurman RG (2001) ICAM-1 is involved in the mechanism of alcohol-induced liver injury: studies with knockout mice. Am J Physiol 280:G1289–G1295
Albano E, French SW, Ingelman-Sundberg M (1999) Hydroxyethyl radicals in ethanol hepatotoxicity. Front Biosci 4:533–540
Stoyanovsky DA, Cederbaum AI (1998) ESR and HPLC-EC analysis of ethanol oxidation to 1-hydroxyethyl radical: rapid reduction and quantification of POBN and PBN nitroxides. Free Radic Biol Med 25:536–545
Clot P, Parola M, Bellomo G, Dianzani U, Carini R, Tabone M, Aricò S, Ingelman-Sundberg M, Albano E (1997) Plasma membrane hydroxyethyl radical adducts cause antibody-dependent cytotoxicity in rat hepatocytes exposed to alcohol. Gastroenterology 113:265–276
Chamulitrat W, Spitzer JJ (1996) Nitric oxide and liver injury in alcohol-fed rats after lipopolysaccaride administration. Alcohol Clin Exp Res 20:1065–1070
Loguercuio C, Federico A (2003) Oxidative stress in viral and alcoholic hepatitis. Free Radic Biol Med 34:1–10
Venkatraman A, Shiva S, Davis AJ, Bailey SM, Brookes PS, Darley-Usmar VM (2003) Chronic alcohol consumption increases the sensitivity of rat liver mitochondrial respiration to inhibition by nitric oxide. Hepatology 38:141–147
Nanji AA, Greenberg SS, Tahan SR, Fogt F, Loscalzo J, Sadrzadeh SMH, Xie J, Stamler JS (1995) Nitric oxide production in experimental alcoholic liver disease in the rat: role in protection from injury. Gastroenterology 109:899–907
Sergent O, Griffon B, Morel I, Chevanne M, Dubus MP, Cillard P, Cillard J (1997) Effect of nitric oxide on iron-mediated oxidative stress in primary hepatocyte culture. Hepatology 23:122–127
Irving MG, Halliday JW, Powell LW (1988) Association between alcoholism and increased hepatic iron store. Alcohol Clin Exp Res 12:7–12
Ioannou GN, Dominitz JA, Weiss NS, Haegerty PJ, Wowdley KV (2004) The effect of alcohol consumption on the prevalence of iron overload, iron deficiency and ion deficiency anemia. Gastroenterology 126:1293–1301
Harrison-Findik DD, Klein E, Crist C, Evans J, Timchenko N, Gollan J (2007) Iron-mediated regulation of liver hepcidin expression in rats and mice is abolished by alcohol. Hepatology 46:1979–1985
Ganz T, Nemeth E (2011) Hepcidin and disorders of iron metabolism. Ann Rev Med 62:347–360
Harrison-Findik DD, Schafer D, Klein E, Timchenko NA, Kulaksiz H, Clemens D, Fein E, Andriopoulos B, Pantopoulos K, Gollan J (2006) Alcohol metabolism-mediated oxidative stress down-regulates hepcidin transcription and leads to increased duodenal iron transporter expression. J Biol Chem 281:22974–22982
Anderson ER, Taylor M, Xue X, Martin A, Moons DS, Omary MB, Shah YM (2012) The hypoxia-inducible factor-C/EBPα axis controls ethanol-mediated hepcidin repression. Mol Cell Biol 32:4068–4077
Wang X, Wu D, Yang L, Gan L, Cederbaum AI (2013) Cytochrome P450 2E1 potentiates ethanol induction of hypoxia and HIF-1α in vivo. Free Radic Biol Med 63:175–186
Costa-Matos L, Batista P, Monteiro N, Simões M, Egas C, Pereira J, Pinho H, Santos N, Ribeiro J, Cipriano MA, Henriques P, Girão F, Rodrigues A, Carvalho A (2012) Liver hepcidin mRNA expression is inappropriately low in alcoholic patients compared with healthy controls. Eur J Gastroenterol Hepatol 24:1158–1165
Xiong S, She H, Zhang AS, Wang J, Mkrtchyan H, Dynnyk A, Gordeuk VR, French SW, Enns CA, Tsukamoto H (2008) Hepatic macrophage iron aggravates experimental alcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 295:G512–G521
Tsukamoto H, Horne W, Kamimura S, Niemelä O, Parkkila S, Ylä-Herttuala S, Brittenham GM (1995) Experimental liver cirrhosis induced by alcohol and iron. J Clin Invest 96:620–630
Iimuro Y, Bradford BU, Yamashina S, Rusyn I, Nakagami M, Enomoto N, Kono H, Frey W, Forman D, Brenner D, Thurman RG (2000) The glutathione precursor L-2-oxothiazolidine-4-carboxylic acid protects against liver injury due to chronic enteral ethanol exposure in the rat. Hepatology 31:391–398
Lu SC, Tzukamoto H, Mato JM (2002) Role of abnormal methionine metabolism in alcoholic liver injury. Alcohol 27:155–162
Purohit V, Abdelmalek MF, Barve S, Benevenga NJ, Halsted CH, Kaplowitz N, Kharbanda KK (2007) Role of S-adenosylmethionine, folate and betaine in the treatment of alcoholic liver disease: summary of a symposium. Am J Clin Nutr 86:14–24
Fernandez-Checa JC, Kaplowitz N (2005) Hepatic mitochondrial glutathione: transport and role in disease and toxicity. Toxicol Appl Pharmacol 204:263–273
Fernandez A, Colell A, Garcia-Ruiz C, Fernandez-Checa JC (2008) Cholesterol and sphingolipids in alcohol-induced liver injury. J Gastroenterol Hepatol 23(Suppl 1):S9–S15
Sadrazadeh SMH, Nanji AA, Meydani M (1994) Effect of chronic ethanol feeding on plasma and liver α- and γ-tocophetol levels in normal and vitamin E-deficient rats. Biochem Pharmacol 47:2005–2010
Gong P, Cederbaum AI (2006) Nrf2 is increased by CYP2E1 in rodent liver HepG2 cells and protects against oxidative stress caused by CYP2E1. Hepatology 43:144–153
Nanji AA, Griniuviene B, Sadrzadeh SMH, Levitsky S, McCully JD (1995) Effect of dietary fat and ethanol on antioxidant enzyme mRNA induction in rat liver. J Lipid Res 36:736–744
Mandrekar P (2011) Epigenetic regulation in alcoholic liver disease. World J Gastroenterol 17:2456–2464
Stewart SF, Leathart JB, Chen Y, Daly AK, Rolla R, Mottaran E, Vay D, Vidali M, Day CP, Albano E (2002) Valine-alanine manganese superoxide dismutase polymorphism is not associated with alcohol-induced oxidative stress or fibrosis. Hepatology 36:1355–1360
Powel EE, Jonsson JR, Clouston AD (2005) Steatosis: co-factor in other liver diseases. Hepatology 42:5–13
Purohit V, Gao B, Song BJ (2009) Molecular mechanisms of alcoholic fatty liver. Alcohol Clin Exp Res 33:1–15
Gao B, Bataller R (2011) Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 141:1572–1585
Sozio M, Crabb DW (2008) Alcohol and lipid metabolism. Am J Physiol Endocrinol Metab 295:E10–E16
Fromenty B, Grimbert S, Mansouri A, Beaugrand M, Erlinger S, Röting A, Pessayre D (1995) Hepatic mitochondrial DNA deletion in alcoholics: association with microvesicular steatosis. Gastroenterology 108:193–200
Malhi H, Kaufman RJ (2011) Endoplasmic reticulum stress in liver disease. J Hepatol 54:795–809
Malhotra JD, Kaufman RJ (2007) Endoplasmic reticulum stress and oxidative stress: a vicious circle or a double-edged sword? Antiox Redox Signal 9:2277–2293
Smalthers RL, Galligan JJ, Stewart BJ, Pettersen DR (2011) Overview of lipid peroxidation products and hepatic protein modification in alcoholic liver disease. Chem Biol Interact 192:107–112
Donohue TM, Cederbaum AI, French SW, Barve S, Gao B, Osna NA (2007) Role of the proteasome in ethanol-induced liver pathology. Alcohol Clin Exp Res 31:1446–1459
Donohue TM (2009) Autophagy and ethanol-induced liver injury. World J Gastroenterol 15:1178–1185
Ji C, Kaplowitz N (2003) Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice. Gastroenterology 124:1488–1499
Lu Y, Zhuge J, Wang X, Bai J, Cederbaum AI (2008) Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice. Hepatology 47:1483–1494
Miller YI, Choi SH, Weisner P, Fang L, Harkewicz R, Hartvigsen K, Buillier A, Gonen A, Diehl CJ, Que X, Montano E, Shaw PX, Tsimikas S, Binder CJ, Witztum JL (2011) Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ Res 108:235–248
Weismann D, Binder CJ (2012) The innate immune response to products of phospholipid peroxidation. Biochim Biophys Acta 1818:2465–2475
Jin C, Flavell RA (2010) Molecular mechanisms of NLPR3 inflammosome activation. J Clin Immunol 30:628–631
Petrasek J, Bala S, Csak T, Lippai D, Kodys K, Menashy V, Barrieau M, Min SY, Kurt-Jones EA, Szabo G (2012) IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J Clin Invest 122:3476–3489
Cohen JI, Chen X, Nagy LE (2011) Redox signaling and the innate immune system in alcoholic liver disease. Antioxid Redox Signal 16:523–534
Wang JH, Gao B, Zakhari S, Nagi LE (2012) Inflammation in alcoholic liver disease. Ann Rev Nutr 32:343–368
Keshavarzian A, Farhadi A, Forsyth CB, Rangan J, Jakate S, Shaikh M, Banan A, Fields JZ (2009) Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats. J Hepatol 50:538–547
Abdelmegeed MA, Banerjee A, Jang S, Yoo SH, Yun JW, Gonzalez FJ, Keshavarzian A, Song BJ (2013) CYP2E1 potentiates binge alcohol-induced gut leakiness steatohepatitis and apoptosis. Free Radic Biol Med 65:1238–1245
Tang Y, Forsyth CB, Banan A, Fields JZ, Keshavarzian A (2009) Oats supplementation prevents alcohol-induced gut leakiness in rats by preventing alcohol-induced oxidative tissue damage. J Pharmacol Exp Ther 329:952–958
Vidali M, Stewart SF, Albano E (2008) Interplay between oxidative stress and immunity in the progression of alcohol-mediated liver injury. Trends Mol Med 14:63–71
Witztum JL, Lichtman AH (2014) Influence of innate and adaptive immune responses on atherosclerosis. Annu Rev Pathol 9:73–102
Kurien BT, Scofield RH (2008) Autoimmunity and oxidatively modified antigens. Autoimmun Rev 7:567–573
Thiele GM, Freeman TK, Klassen LW (2004) Immunological mechanisms of alcoholic liver disease. Sem Liver Dis 24:273–287
Stewart SF, Vidali M, Day CP, Albano E, Jones DEJ (2004) Oxidative stress as a trigger for cellular immune response in patients with alcoholic liver disease. Hepatology 39:197–203
Vay D, Rigamonti C, Vidali M, Mottaran E, Alchera E, Occhino G, Sartori M, Albano E (2006) Anti-phospholipid antibodies associated with alcoholic liver disease target oxidized phosphatidylserine on apoptotic cell plasma membranes. J Hepatol 44:183–189
Ronis MJ, Butura A, Korourian S, Shankar K, Simpson P, Badeaux J, Albano E, Ingelman-Sundberg M, Badger TM (2008) Cytokine and chemokine expression associated with steatohepatitis and hepatocyte proliferation in rats fed ethanol via total enteral nutrition. Exp Biol Med 233:344–355
Vidali M, Vietala J, Occhino G, Ivaldi A, Sutti S, Niemelä O, Albano E (2008) Immune responses against oxidative stress-derived antigens are associated with increased circulating tumor necrosis factor-α and accelerated liver damage in heavy drinkers. Free Radic Biol Med 45:306–311
Vidali M, Occhino G, Ivaldi A, Rigamonti C, Sartori M, Albano E (2008) Combination of oxidative stress and steatosis is a risk factor for fibrosis in alcohol-drinking patients with chronic hepatitis C. Am J Gastroenterol 103:147–153
Albano E, Mottaran E, Vidali M, Reale E, Saksena S, Occhino D, Burt AD, Day CP (2005) Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis. Gut 54:987–993
Nobili V, Parola M, Alisi A, Marra F, Piemonte F, Mombello C, Sutti S, Povero D, Maina V, Novo E, Albano E (2010) Oxidative stress papameters in paediatric non-alcoholic fatty liver disease. Int J Mol Med 26:471–476
Sutti S, Jindal A, Locatelli I, Vacchiano M, Gigliotti L, Bozzola C, Albano E (2014) Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH. Hepatology 59:886–897
Colombat M, Charlotte F, Ratziu V, Poyard T (2002) Portal lymphocytic infiltrate in alcoholic liver disease. Hum Pathol 33:1170–1174
Batey RG, Cao Q, Gould B (2002) Lymphocyte-mediated liver injury in alcohol-related hepatitis. Alcohol 27:37–41
Lemmers A, Moreno C, Gustot T, Maréchal R, Degreé D, Demetter P, de Nadal P, Geerts A, Quertinmont E, Vercruysse V, Le Moine O, Devière J (2009) The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology 49:646–657
Vidali M, Stewart SF, Rolla R, Daly AK, Chen Y, Mottaran E, Jones DEJ, Leathart JB, Day CP, Albano E (2003) Genetic and epigenetic factors in autoimmune reactions toward cytochrome P4502E1 in alcoholic liver disease. Hepatology 37:277–285
Natori S, Rust C, Stadheim LM, Srinivasan A, Burgart LJ, Gores GJ (2001) Hepatocyte apoptosis is a pathological feature of human alcoholic hepatitis. J Hepatol 34:248–253
Eguchi A, Wree A, Feldstein AE (2014) Biomarkers of cells death. J Hepatol 60:1063–1074
Adachi M, Ishii H (2002) Role of mitochondria in alcoholic liver injury. Free Radic Bio Med 32:487–491
Kessova IG, Cederbaum AI (2007) Mitochondrial alterations in livers of SOD1−/− mice fed alcohol. Free Radic Biol Med 42:1470–1480
Ji C, Mehrian-Shai R, Chan C, Hsu YH, Kaplowitz N (2005) Role of CHOP in hepatic apoptosis in the murine model of intragastric ethanol feeding. Alcohol Clin Exp Res 29:1496–1503
Bardag-Gorce F, French BA, Nan L, Song H, Nguyen SK, Yong H, Dede J, French SW (2006) CYP2E1 induced by ethanol causes oxidative stress, proteasome inhibition and cytokeratin aggresome (Mallory body-like) formation. Exp Mol Pathol 81:191–201
Malhi H, Guicciardi ME, Gores GJ (2010) Hepatocyte death: a clear and present danger. Physiol Rev 90:1165–1194
Mari M, Colell A, Morales A, Caballero F, Moles A, Fernández A, Terrones O, Basañez G, Antonsson B, GarcÃa-Ruiz C, Fernández-Checa JC (2008) Mechanism of mitochondrial glutathione-dependent hepatocellular susceptibility to TNF despite NF-kB activation. Gastroenterology 134:1507–1520
Hoek JB, Pastorino JG (2004) Cellular signaling mechanisms in alcoholic liver damage. Sem Liver Dis 24:257–272
Sampey BP, Stewart BJ, Petersen DR (2007) Ethanol-induced modulation of hepatocellular extracellular signal-regulated kinase 1/2 activity via 4-hydroxynonenal. J Biol Chem 282:1925–1937
Sid B, Verrax J, Calderon PB (2013) Role of AMPK activation in oxidative cell damage: implication for alcohol-induced liver disease. Biochem Pharmacol 86:200–209
Shearn CT, Backos DS, Orlicky DJ, Smathers-McCullough RL, Petersen DR (2014) Identification of 5′ AMP activated kinase as a target of reactive aldehydes during chronic ingestion of high concentrations of ethanol. J Biol Chem 289:15449–15462
Hoare M, Das T, Alexander G (2010) Ageing, telomeres, senescence and liver injury. J Hepatol 53:950–961
Diehl AM (2005) Recent events in alcoholic liver disease V. Effect of ethanol on liver regeneration. Am J Physiol Gastrointest Liver Physiol 288:G1–G6
Roskams T, Yang SQ, Koteish A, Durnez A, DeVos R, Huang X, Achten R, Verslype C, Diehl AM (2003) Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. Am J Pathol 163:1301–1311
Jung Y, Brown KD, Witek RP, Omenetti A, Yang L, Vandongen M, Milton RJ, Hines IN, Rippe RA, Spahr L, Rubbia-Brandt L, Diehl AM (2008) Accumulation of hedgehog-responsive progenitors paralles alcoholic liver disease in mice and humans. Gastroenterology 134:1532–1543
Ding X, Beier JI, Baldauf KJ, Jokinen JD, Zhong H, Arlteel GE (2014) Acute ethanol preexposure promotes liver regeneration after partiel hepatectomy by activating ALDH2. Am J Physiol 306:G37–G47
Friedman SL (2008) Mechanism of hepatic fibrogenesis. Gastroenterology 134:1655–1669
Pellicoro A, Ramachandran P, Iredale JP, Fallowfield JA (2014) Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol 14:181–194
Novo E, Parola M (2008) Redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogenesis Tissue Repair 1:5. doi:10.1186/1755-1536-1-5
Novo E, Busletta C, Bonzo LV, Povero D, Paternostro C, Mareschi K, Ferrero I, David E, Bertolani C, Caligiuri A, Cannito S, Tamagno E, Compagnone A, Colombatto S, Marra F, Fagioli F, Pinzani M, Parola M (2011) Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells. J Hepatol 54:964–974
Colmenero J, Balaller R, Sancho-Bru P, Bellot P, Miguel R, Moreno M, Jares P, Bosch J, Arroyo V, Caballeira J, Gines P (2007) Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlations with disease severity. Gastroenterology 132:687–697
Nieto N, Greenwel P, Friedman SL, Zhang F, Dannenberg AJ, Cederbaum AJ (2000) Ethanol and arachidonic acid increase α2(1) collagen expression in rat hepatic stellate cells over-expression cytochrome P450 2E1. J Biol Chem 26:20136–20145
Nieto N (2007) Ethanol and fish oil induce NFkB transactivation of the collagen α2(1) promoter through lipid peroxidation-driven activation of PKC-PI3K-Akt pathway. Hepatology 45:1433–1445
Nieto N, Friedman SL, Cederbaum AJ (2002) Cytochrome P4502E1-derived reactive oxygen species mediate paracrine of collagen 1 protein synthesis by hepatic stellate cells. J Biol Chem 277:9853–9864
Kamimura S, Tsukamoto H (1995) Cytokine gene expression by kupffer cells in experimental alcoholic liver disease. Hepatology 21:1304–1309
Fang C, Lindros KO, Badger TM, Ronis JJ, Ingelman-Sundberg M (1998) Zonated expression of cytokines in rat liver: effect of chronic ethanol and cytochrome P4502E1 inhibitor, chlormethiazole. Hepatology 27:1304–1310
Nieto N, Rojkind M (2007) Repeated whiskey binges promote liver injury in rats fed a choline-deficient diet. J Hepatol 46:330–339
Mezey E, Potter JJ, Rennie-Tankersley L, Caballeire J, Pares A (2004) A randomized placebo controlled trial of vitamin E for alcoholic hepatitis. J Hepatol 40(1):40–46
Phillips M, Curtis H, Portmann B, Donaldson N, Bomford A, O’Grady J (2006) Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis: a randomised clinical trial. J Hepatol 44:784–790
Stewart S, Prince M, Bassendine M, Hudson M, James O, Jones D, Record C, Day CP (2007) A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis. J Hepatol 47:277–283
Singal AK, Jampana SC, Weinman SA (2011) Antioxidants as therapeutic agents for liver disease. Liver Int 31:1432–1448
Rambaldi A, Jacobs BP, Iaquinto G, Gluud C (2005) Milk thistle for alcoholic and/or hepatitis B or C liver diseases–a systematic Cochrane hepato-biliary group review with meta-analyses of randomized clinical trials. Am J Gastroenterol 100:2583–2591
Rambaldi A, Gluud C (2006) S-adenosyl-L-methionine for alcoholic liver diseases. Cochrane Database Syst Rev 19, CD002235
Pacana T, Sanyal AJ (2012) Vitamin E and nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care 15:641–648
Gambino R, Musso G, Cassader M (2011) Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities. Antioxid Redox Signal 15:1325–1365
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Albano, E. (2015). Oxidative Stress in Alcoholic Liver Disease. In: Albano, E., Parola, M. (eds) Studies on Hepatic Disorders. Oxidative Stress in Applied Basic Research and Clinical Practice. Humana Press, Cham. https://doi.org/10.1007/978-3-319-15539-5_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-15539-5_10
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-15538-8
Online ISBN: 978-3-319-15539-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)